Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy

Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy

US Patent 11779558 · Granted Oct 10, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of diseases by concurrently eliciting remyelination effects and immuno2025
Treatment of diseases by concurrently eliciting remyelination effects and immuno2025
Combination therapy for the treatment of migraines2025
RXR agonist salt form, polymorphs thereof, and uses thereof2025
Methods of using RARγ agonists for cancer treatment2024
Use of an RXR agonist in treating drug resistant HER2+ cancers2024
RXR agonist salt form, polymorphs thereof, and uses thereof2024
Use of an RXR agonist and taxanes in treating Her2+ cancers2024
Autoimmune disorder treatment using RXR agonists2023
Methods of using RARγ agonists for cancer treatment2023
RAR selective agonists in combination with immune modulators for cancer immunoth2023
RAR selective agonists in combination with immune modulators for cancer immunoth2023